Organization and Nature of the Business - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands					1 Months Ended		12 Months Ended
	Jan. 23, 2024	Jan. 22, 2024	Aug. 31, 2022	Mar. 12, 2021	Jan. 31, 2024	Nov. 30, 2022	Dec. 31, 2024	Dec. 31, 2023
Schedule Of Equity Method Investments [Line Items]
Accumulated deficit							$ 497,894	$ 380,772
Underwriting discounts and commissions and other offering expenses		$ 91,700
Proceeds from issuance of common stock pursuant to at-the-market offering, net of issuance costs							$ 19,266	$ 0
Common stock, shares issued		5,325,000					82,569,168	43,270,386
Common stock price per share		$ 0.0001					$ 0.0001	$ 0.0001
Exercise price		2.3999
Estimated offering expenses	$ 91,700
Common stock, shares outstanding							82,569,168	43,270,386
Sales Agreement [Member]
Schedule Of Equity Method Investments [Line Items]
Proceeds from issuance of common stock pursuant to at-the-market offering, net of issuance costs						$ 100,000
Aggregate number of shares sold			2,611,723
Sale of Stock, Price Per Share			$ 17.23
Sales agent commissions and expenses			$ 43,400
Common Stock not sold						30,000
Additional Common Stock not sold						$ 70,000
aggregate net proceed					$ 19,300
Jefferies LLC [Member]
Schedule Of Equity Method Investments [Line Items]
Issuance price per shares		$ 2.256
Common Stock
Schedule Of Equity Method Investments [Line Items]
Common stock, shares issued		5,325,000
Common Stock | Jefferies LLC [Member]
Schedule Of Equity Method Investments [Line Items]
Common stock, shares issued		27,054,667
Common stock price per share		$ 0.0001
Warrants outstanding		8,445,333
Exercise price		$ 2.4
Pre Funded Warrant [Member] | Jefferies LLC [Member]
Schedule Of Equity Method Investments [Line Items]
Issuance price per shares		2.2559
Exercise price		$ 2.3999
Discount On Under writers Warrant		6.00%
Underwriting Agreement to purchase					30
Maximum [Member] | Sales Agreement [Member]
Schedule Of Equity Method Investments [Line Items]
Proceeds from issuance of common stock pursuant to at-the-market offering, net of issuance costs				$ 75,000
Adicet Therapeutics [Member]
Schedule Of Equity Method Investments [Line Items]
Accumulated deficit							$ (497,900)
Initial Public Offering | Pre Funded Warrant [Member] | Jefferies LLC [Member]
Schedule Of Equity Method Investments [Line Items]
Exercise price		$ 0.0001